IBDEI2LJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43579,0)
 ;;=L03.891^^200^2212^35
 ;;^UTILITY(U,$J,358.3,43579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43579,1,3,0)
 ;;=3^Lymphangitis,Head (Except Face),Acute
 ;;^UTILITY(U,$J,358.3,43579,1,4,0)
 ;;=4^L03.891
 ;;^UTILITY(U,$J,358.3,43579,2)
 ;;=^5009065
 ;;^UTILITY(U,$J,358.3,43580,0)
 ;;=L03.898^^200^2212^36
 ;;^UTILITY(U,$J,358.3,43580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43580,1,3,0)
 ;;=3^Lymphangitis,Oth Sites,Acute
 ;;^UTILITY(U,$J,358.3,43580,1,4,0)
 ;;=4^L03.898
 ;;^UTILITY(U,$J,358.3,43580,2)
 ;;=^5009066
 ;;^UTILITY(U,$J,358.3,43581,0)
 ;;=L03.90^^200^2212^12
 ;;^UTILITY(U,$J,358.3,43581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43581,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,43581,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,43581,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,43582,0)
 ;;=L03.91^^200^2212^34
 ;;^UTILITY(U,$J,358.3,43582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43582,1,3,0)
 ;;=3^Lymphangitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,43582,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,43582,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,43583,0)
 ;;=M51.26^^200^2212^32
 ;;^UTILITY(U,$J,358.3,43583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43583,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbar Region
 ;;^UTILITY(U,$J,358.3,43583,1,4,0)
 ;;=4^M51.26
 ;;^UTILITY(U,$J,358.3,43583,2)
 ;;=^5012249
 ;;^UTILITY(U,$J,358.3,43584,0)
 ;;=M51.27^^200^2212^33
 ;;^UTILITY(U,$J,358.3,43584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43584,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbosacral Region
 ;;^UTILITY(U,$J,358.3,43584,1,4,0)
 ;;=4^M51.27
 ;;^UTILITY(U,$J,358.3,43584,2)
 ;;=^5012250
 ;;^UTILITY(U,$J,358.3,43585,0)
 ;;=G47.33^^200^2212^51
 ;;^UTILITY(U,$J,358.3,43585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43585,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,43585,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,43585,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,43586,0)
 ;;=G44.1^^200^2212^55
 ;;^UTILITY(U,$J,358.3,43586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43586,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,43586,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,43586,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,43587,0)
 ;;=R73.01^^200^2212^30
 ;;^UTILITY(U,$J,358.3,43587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43587,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,43587,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,43587,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,43588,0)
 ;;=R74.8^^200^2212^1
 ;;^UTILITY(U,$J,358.3,43588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43588,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,43588,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,43588,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,43589,0)
 ;;=R97.2^^200^2212^18
 ;;^UTILITY(U,$J,358.3,43589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43589,1,3,0)
 ;;=3^Elevated Prostate Specific Antigen
 ;;^UTILITY(U,$J,358.3,43589,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,43589,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,43590,0)
 ;;=R03.0^^200^2212^17
 ;;^UTILITY(U,$J,358.3,43590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43590,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,43590,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,43590,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,43591,0)
 ;;=Z91.19^^200^2212^42
 ;;^UTILITY(U,$J,358.3,43591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43591,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,43591,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,43591,2)
 ;;=^5063618
